Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees
The Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees and The Investigation of The Relationship Between Compliance With a Prosthesis, Balance, and Functional Performance With Joint Position Sense
1 other identifier
interventional
32
1 country
1
Brief Summary
This study evaluated the effect of joint position sense on compliance with the prosthesis, balance and functional performance in individuals with lower extremity amputation due to diabetic polyneuropathy. Study group consisted of 16 subjects with unilateral transtibial amputation due to diabetic polyneuropathy and control group consisted of 16 subjects with unilateral transtibial amputation due to traumatic reasons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2022
CompletedStudy Start
First participant enrolled
September 13, 2022
CompletedFirst Posted
Study publicly available on registry
September 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2023
CompletedJune 12, 2023
June 1, 2023
8 months
September 13, 2022
June 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Joint Position Sense
The Xsens DOT Motion Capture System will be used in the evaluation of knee joint proprioception. . Before starting the measurement, the sensors are properly attached to the patient. The sense of proprioception of the knee joint will be evaluated bilaterally with weightless (NWB) using the method. The NWB assessment will be performed with and without prosthesis while the person is in a sitting position with their legs fully supported. The person's eyes will be covered with a band aid to avoid any visual cues. The knee joint in extension position will be slowly brought to the target angle value of 30° and 60° flexion position by the physiotherapist and waited for 4 seconds. After 3 consecutive attempts, the participant will be asked to actively perform the flexion movement whose angle is determined using the same limb. There will be 2 minute rest breaks between measurements. The difference between the target angle and the measured angle is recorded as the margin of error.
1 week
Secondary Outcomes (3)
The Limits of Stability
1 week
Postural Sway
1 week
Functional Capacity
1 week
Study Arms (2)
Diabetic Group (DG)
OTHERExamine the effect of joint position sense on compliance with the prosthesis, balance and functional performance in individuals with lower extremity amputation due to diabetic polyneuropathy.
Traumatic Group (TG)
OTHERExamine the effect of joint position sense on compliance with the prosthesis, balance and functional performance in individuals with lower extremity amputation due to traumatic causes.
Interventions
The Xsens DOT Motion Capture System will be used to analyze joint position sense.
Eligibility Criteria
You may qualify if:
- Diabetic Group (DG):
- Those who had unilateral transtibial amputation due to DPN
- Between the ages of 40-65
- Completed rehabilitation with prosthesis
- Using prosthesis for at least 1 year
- With standard size stump length
- Without phantom sensation and pain
- Able to walk at least 10 m independently
- Gross lower extremity muscle strength at least moderate
- No cognitive and mental problems
- Diabetic nephropathy, retinopathy, ulceration etc. without secondary complications
- Those who voluntarily agreed to participate in the research
- Not included in any other concurrent study
- Traumatic Group (TG):
- Those who had trauma-induced unilateral transtibial amputation
- +10 more criteria
You may not qualify if:
- For all groups;
- Having osteoarticular deformity in the knee joint
- Having an orthopedic or neurological disease other than the cause of amputation
- Significant and irreversible visual deficit
- Body mass index (BMI)\>30 kg/m²
- Having a disability that makes it hard to complete any of the tests
- Individuals with a history of cancer and receiving chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Altindag, 06230, Turkey (Türkiye)
Related Publications (1)
Fontes Filho CHDS, Laett CT, Gavilao UF, Campos JC Jr, Alexandre DJA, Cossich VRA, Sousa EB. Bodyweight distribution between limbs, muscle strength, and proprioception in traumatic transtibial amputees: a cross-sectional study. Clinics (Sao Paulo). 2021 Apr 26;76:e2486. doi: 10.6061/clinics/2021/e2486. eCollection 2021.
PMID: 33909824BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melek M. ERDEM, PT, M.Sc.
Tayyip Erdogan University Training and Research Hospital
- STUDY DIRECTOR
Semra TOPUZ, PT, Prof.
Hacettepe University
- STUDY CHAIR
Ali I. YALCIN, PT, Ph.D.
Hacettepe University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
September 13, 2022
First Posted
September 16, 2022
Study Start
September 13, 2022
Primary Completion
May 15, 2023
Study Completion
June 9, 2023
Last Updated
June 12, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- Data will be available within 3 months with completion of the result report.
- Access Criteria
- Requestors will be required to sign a Data Access Agreement.
De-identified individual participant data for all primary and secondary outcome measures will be made available.